{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T13:07:14Z","timestamp":1763212034332,"version":"3.45.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grant \u201cDirection G\u00e9n\u00e9rale de l\u2019Offre de Soins\u201d for the implementation of clinical pharmacy activities in French hospitals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00520-025-09996-4","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T23:51:07Z","timestamp":1760485867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with medication adherence trajectory among patients treated with oral anticancer drugs: a multicentre cohort study"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-1777","authenticated-orcid":false,"given":"Germain","family":"Perrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8240-1478","authenticated-orcid":false,"given":"Audrey","family":"Thomas-Schoemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1503-0723","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4860-305X","authenticated-orcid":false,"given":"Pascaline","family":"Boudou-Rouquette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8286-7868","authenticated-orcid":false,"given":"Nicolas","family":"Delanoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0569-692X","authenticated-orcid":false,"given":"Claire","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-8506","authenticated-orcid":false,"given":"Justine","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-3644","authenticated-orcid":false,"given":"Rui","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3096-4305","authenticated-orcid":false,"given":"Benoit","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-0842","authenticated-orcid":false,"given":"Jean-St\u00e9phane","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1643-2070","authenticated-orcid":false,"given":"Brigitte","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3496-6244","authenticated-orcid":false,"given":"Virginie","family":"Korb-Savoldelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"9996_CR1","unstructured":"D\u00e9veloppement des anticanc\u00e9reux oraux - Projections \u00e0 court, moyen et long termes - Ref\u202f: ETATDEVANTIKOR17 [Internet]. [cited 2024 Jun 21]. Available from: https:\/\/www.e-cancer.fr\/Expertises-et-publications\/Catalogue-des-publications\/Developpement-des-anticancereux-oraux-Projections-a-court-moyen-et-long-termes"},{"issue":"612","key":"9996_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.actpha.2021.12.006","volume":"61","author":"P Coudert","year":"2022","unstructured":"Coudert P (2022) Les chimioth\u00e9rapies orales, une avanc\u00e9e dans le traitement des cancers. Actual Pharm 61(612):23\u201326. https:\/\/doi.org\/10.1016\/j.actpha.2021.12.006","journal-title":"Actual Pharm"},{"issue":"S4","key":"9996_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1634\/theoncologist.6-suppl_4-12","volume":"6","author":"M Borner","year":"2001","unstructured":"Borner M, Scheithauer W, Twelves C, Maroun J, Wilke H (2001) Answering patients\u2019 needs: oral alternatives to intravenous therapy. Oncologist 6(S4):12\u201316. https:\/\/doi.org\/10.1634\/theoncologist.6-suppl_4-12","journal-title":"Oncologist"},{"key":"9996_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/11786329231196029","volume":"16","author":"I Aubert","year":"2023","unstructured":"Aubert I, Kletz F, Sardas J-C (2023) The patient as an actor in his care pathway: insights from the French case. Health Serv Insights 16:11786329231196028. https:\/\/doi.org\/10.1177\/11786329231196029","journal-title":"Health Serv Insights"},{"key":"9996_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/15265160802654111","volume":"9","author":"AD Naik","year":"2009","unstructured":"Naik AD, Dyer CB, Kunik ME, McCullough LB (2009) Patient autonomy for the management of chronic conditions: a two-component re-conceptualization. Am J Bioeth 9:23\u201330. https:\/\/doi.org\/10.1080\/15265160802654111","journal-title":"Am J Bioeth"},{"key":"9996_CR6","doi-asserted-by":"publisher","first-page":"E374","DOI":"10.1097\/NCC.0000000000000934","volume":"45","author":"M Mason","year":"2022","unstructured":"Mason M, Harris MR, Greer JA, Jiang Y (2022) A concept analysis of oral anticancer agent self-management. Cancer Nurs 45:E374\u2013E387. https:\/\/doi.org\/10.1097\/NCC.0000000000000934","journal-title":"Cancer Nurs"},{"key":"9996_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/sj.bjc.6601560","volume":"90","author":"U Werneke","year":"2004","unstructured":"Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D (2004) Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 90:408\u2013413. https:\/\/doi.org\/10.1038\/sj.bjc.6601560","journal-title":"Br J Cancer"},{"key":"9996_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12185-011-0838-3","volume":"93","author":"C Yoshida","year":"2011","unstructured":"Yoshida C, Komeno T, Hori M, Kimura T, Fujii M, Okoshi Y et al (2011) Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia. Int J Hematol 93:618\u2013623. https:\/\/doi.org\/10.1007\/s12185-011-0838-3","journal-title":"Int J Hematol"},{"key":"9996_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ctrv.2012.12.014","volume":"39","author":"M Verbrugghe","year":"2013","unstructured":"Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A (2013) Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev 39:610\u2013621. https:\/\/doi.org\/10.1016\/j.ctrv.2012.12.014","journal-title":"Cancer Treat Rev"},{"key":"9996_CR10","first-page":"231","volume":"15","author":"DM Geynisman","year":"2013","unstructured":"Geynisman DM, Wickersham KE (2013) Adherence to targeted oral anticancer medications. Discov Med. 15:231\u201341 (PMID: 23636140; PMCID: PMC6477693)","journal-title":"Discov Med."},{"key":"9996_CR11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1200\/JCO.2003.07.071","volume":"21","author":"AH Partridge","year":"2003","unstructured":"Partridge AH, Wang PS, Winer EP, Avorn J (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21:602\u2013606. https:\/\/doi.org\/10.1200\/JCO.2003.07.071","journal-title":"J Clin Oncol"},{"key":"9996_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1078155214559114","volume":"22","author":"MA Felton","year":"2016","unstructured":"Felton MA, Van Londen G, Marcum ZA (2016) Medication adherence to oral cancer therapy: the promising role of the pharmacist. J Oncol Pharm Pract 22:378\u2013381. https:\/\/doi.org\/10.1177\/1078155214559114","journal-title":"J Oncol Pharm Pract"},{"key":"9996_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.phclin.2021.05.002","volume":"56","author":"AM Joy","year":"2021","unstructured":"Joy AM, Up N, Chand S, Shetty KJ, George SM, Chacko CS et al (2021) Role of clinical pharmacist in the medication adherence behaviour of cancer patients: An interventional study. Pharm Hosp Clin 56:291\u2013297. https:\/\/doi.org\/10.1016\/j.phclin.2021.05.002","journal-title":"Pharm Hosp Clin"},{"key":"9996_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","volume":"126","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529\u2013537. https:\/\/doi.org\/10.1007\/s10549-010-1132-4","journal-title":"Breast Cancer Res Treat"},{"key":"9996_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/14737167.2023.2266135","volume":"24","author":"AP Kengne","year":"2024","unstructured":"Kengne AP, Bri\u00e8re J-B, Zhu L, Li J, Bhatia MK, Atanasov P et al (2024) Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and\/or dyslipidemia: systematic review. Expert Rev Pharmacoecon Outcomes Res 24:143\u2013154. https:\/\/doi.org\/10.1080\/14737167.2023.2266135","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"9996_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ajh.22019","volume":"86","author":"P Ganesan","year":"2011","unstructured":"Ganesan P, Sagar TG, Dubashi B, Rajendranath R, Kannan K, Cyriac S et al (2011) Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia. Am J Hematol 86:471\u2013474. https:\/\/doi.org\/10.1002\/ajh.22019","journal-title":"Am J Hematol"},{"key":"9996_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/34833","volume":"8","author":"TH Dang","year":"2022","unstructured":"Dang TH, Forkan ARM, Wickramasinghe N, Jayaraman PP, Alexander M, Burbury K et al (2022) Investigation of intervention solutions to enhance adherence to oral anticancer medicines in adults: overview of reviews. JMIR Cancer 8:e34833. https:\/\/doi.org\/10.2196\/34833","journal-title":"JMIR Cancer"},{"key":"9996_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.sapharm.2014.08.006","volume":"11","author":"J Kavookjian","year":"2015","unstructured":"Kavookjian J, Wittayanukorn S (2015) Interventions for adherence with oral chemotherapy in hematological malignancies: a systematic review. Res Social Adm Pharm 11:303\u2013314. https:\/\/doi.org\/10.1016\/j.sapharm.2014.08.006","journal-title":"Res Social Adm Pharm"},{"key":"9996_CR19","unstructured":"Organization WH. Adherence to long-term therapies\u202f: evidence for action [Internet]. World Health Organization; 2003 [cited 2025 Jun 20]. Available from: https:\/\/iris.who.int\/handle\/10665\/42682"},{"issue":"4","key":"9996_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/jcpt.12562","volume":"42","author":"LRP Colombo","year":"2017","unstructured":"Colombo LRP, Aguiar PM, Lima TM, Storpirtis S (2017) The effects of pharmacist interventions on adult outpatients with cancer: a systematic review. J Clin Pharm Ther 42(4):414\u2013424. https:\/\/doi.org\/10.1111\/jcpt.12562","journal-title":"J Clin Pharm Ther"},{"key":"9996_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1078155217727820","volume":"25","author":"MW Mawhinney","year":"2019","unstructured":"Mawhinney MW, Warden J, Stoner N (2019) The oral education clinic: a pharmacist- and nurse-led clinic to support patients starting oral systemic anti-cancer treatments. J Oncol Pharm Pract 25:449\u2013453. https:\/\/doi.org\/10.1177\/1078155217727820","journal-title":"J Oncol Pharm Pract"},{"key":"9996_CR22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/CLEP.S265287","volume":"Volume 12","author":"HL Nguena Nguefack","year":"2020","unstructured":"Nguena Nguefack HL, Pag\u00e9 MG, Katz J, Choini\u00e8re M, Vanasse A, Dorais M et al (2020) Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches. Clin Epidemiol Volume 12:1205\u20131222. https:\/\/doi.org\/10.2147\/CLEP.S265287","journal-title":"Clin Epidemiol"},{"key":"9996_CR23","first-page":"1044","volume":"30","author":"X Girerd","year":"2001","unstructured":"Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S (2001) Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic. Presse Med Paris Fr 30:1044\u20131048","journal-title":"Presse Med Paris Fr"},{"key":"9996_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100672","volume":"31","author":"M Sapoval","year":"2023","unstructured":"Sapoval M, Thiounn N, Descazeaud A, D\u00e9an C, Ruffion A, Pagnoux G et al (2023) Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. The Lancet Regional Health 31:100672. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100672","journal-title":"The Lancet Regional Health"},{"key":"9996_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215415","volume":"14","author":"M Sustersic","year":"2019","unstructured":"Sustersic M, Gauchet A, Duvert A, Gonnet L, Foote A, Vermorel C et al (2019) Proposal for a global adherence scale for acute conditions (GASAC): a prospective cohort study in two emergency departments. PLoS ONE 14:e0215415. https:\/\/doi.org\/10.1371\/journal.pone.0215415","journal-title":"PLoS ONE"},{"key":"9996_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00280-023-04574-z","volume":"93","author":"C Tardy","year":"2024","unstructured":"Tardy C, Puszkiel A, Boudou-Rouquette P, De Percin S, Alexandre J, Berge M et al (2024) Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection. Cancer Chemother Pharmacol 93:169\u2013175. https:\/\/doi.org\/10.1007\/s00280-023-04574-z","journal-title":"Cancer Chemother Pharmacol"},{"key":"9996_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10067-019-04837-2","volume":"39","author":"C Monchablon","year":"2020","unstructured":"Monchablon C, Gond\u00e9 H, Pouplin S, Varin R, Vittecoq O, Lequerr\u00e9 T (2020) Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis. Clin Rheumatol 39:207\u2013216. https:\/\/doi.org\/10.1007\/s10067-019-04837-2","journal-title":"Clin Rheumatol"},{"key":"9996_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113718","volume":"193","author":"D Balakirouchenane","year":"2021","unstructured":"Balakirouchenane D, Khoudour N, Gu\u00e9gan S, Kramkimel N, Franck N, Rodier T et al (2021) Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 193:113718. https:\/\/doi.org\/10.1016\/j.jpba.2020.113718","journal-title":"J Pharm Biomed Anal"},{"key":"9996_CR29","unstructured":"Nomenclatures des professions et cat\u00e9gories socioprofessionnelles | Insee [Internet]. [cited 2025 Jun 20]. Available from: https:\/\/www.insee.fr\/fr\/information\/2406153"},{"key":"9996_CR30","unstructured":"Organization WH. WHO European regional obesity report 2022. WHO Eur Reg Obes Rep 2022 [Internet]. 2022 [cited 2025 Aug 5]. Available from: https:\/\/pesquisa.bvsalud.org\/portal\/resource\/pt\/who-353747"},{"key":"9996_CR31","unstructured":"Diagnostic de la d\u00e9nutrition de l\u2019enfant et de l\u2019adulte [Internet]. Haute Aut. Sant\u00e9. [cited 2025 Aug 5]. Available from: https:\/\/www.has-sante.fr\/jcms\/p_3118872\/fr\/diagnostic-de-la-denutrition-de-l-enfant-et-de-l-adulte"},{"key":"9996_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D, Guidi J, Patierno C (2022) Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom 91:8\u201335. https:\/\/doi.org\/10.1159\/000521288","journal-title":"Psychother Psychosom"},{"key":"9996_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17:230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2","journal-title":"BMC Geriatr"},{"key":"9996_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"9996_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, Ford R, Gwyther S, Mandrekar S et al (2016) RECIST 1.1-update and clarification: from the RECIST committee. Eur J Cancer 62:132\u2013137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"key":"9996_CR36","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP [Internet]. [cited 2022 May 6]. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm"},{"key":"9996_CR37","unstructured":"D\u00e9cret n\u00b0 2016\u20131537 du 16 Novembre 2016 relatif aux recherches impliquant la personne humaine. 2016\u20131537 Nov 16, 2016."},{"key":"9996_CR38","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1177\/0962280216673085","volume":"27","author":"DS Nagin","year":"2018","unstructured":"Nagin DS, Jones BL, Passos VL, Tremblay RE (2018) Group-based multi-trajectory modeling. Stat Methods Med Res 27:2015\u20132023. https:\/\/doi.org\/10.1177\/0962280216673085","journal-title":"Stat Methods Med Res"},{"key":"9996_CR39","doi-asserted-by":"publisher","unstructured":"Alessandro Magrini. gbmt: group-based multivariate trajectory modeling [Internet]. 2021 [cited 2024 Jun 21]. p. 0.1.3. https:\/\/doi.org\/10.32614\/CRAN.package.gbmtAvailable from: https:\/\/CRAN.R-project.org\/package=gbmt","DOI":"10.32614\/CRAN.package.gbmtAvailable"},{"key":"9996_CR40","unstructured":"Ripley B, Venables W. nnet: feed-forward neural networks and multinomial log-linear models [Internet]. 2025 [cited 2025 Jun 20]. Available from: https:\/\/cran.r-project.org\/web\/packages\/nnet\/index.html"},{"key":"9996_CR41","unstructured":"Fox J, Weisberg S, Price B, Adler D, Bates D, Baud-Bovy G, et al. car: Companion to applied regression [Internet]. 2024 [cited 2025 Aug 5]. Available from: https:\/\/cran.r-project.org\/web\/packages\/car\/index.html"},{"key":"9996_CR42","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2015.11082","volume":"314","author":"MJ Pencina","year":"2015","unstructured":"Pencina MJ, D\u2019Agostino RB (2015) Evaluating discrimination of risk prediction models: the C statistic. JAMA 314:1063. https:\/\/doi.org\/10.1001\/jama.2015.11082","journal-title":"JAMA"},{"key":"9996_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00228-020-03014-8","volume":"77","author":"A Mueller-Schoell","year":"2021","unstructured":"Mueller-Schoell A, Groenland SL, Scherf-Clavel O, van Dyk M, Huisinga W, Michelet R et al (2021) Therapeutic drug monitoring of oral targeted antineoplastic drugs. Eur J Clin Pharmacol 77:441\u2013464. https:\/\/doi.org\/10.1007\/s00228-020-03014-8","journal-title":"Eur J Clin Pharmacol"},{"key":"9996_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H (2018) User\u2019s guide to correlation coefficients. Turk J Emerg Med 18:91\u201393. https:\/\/doi.org\/10.1016\/j.tjem.2018.08.001","journal-title":"Turk J Emerg Med"},{"key":"9996_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"9996_CR46","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1185\/03007990903126833","volume":"25","author":"S Karve","year":"2009","unstructured":"Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC (2009) Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 25:2303\u20132310. https:\/\/doi.org\/10.1185\/03007990903126833","journal-title":"Curr Med Res Opin"},{"key":"9996_CR47","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.18553\/jmcp.2020.26.9.1138","volume":"26","author":"M Alhazami","year":"2020","unstructured":"Alhazami M, Pontinha VM, Patterson JA, Holdford DA (2020) Medication adherence trajectories: a systematic literature review. J Manag Care Spec Pharm 26:1138\u20131152. https:\/\/doi.org\/10.18553\/jmcp.2020.26.9.1138","journal-title":"J Manag Care Spec Pharm"},{"key":"9996_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1345\/aph.1K671","volume":"43","author":"BC Martin","year":"2009","unstructured":"Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL (2009) Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 43:36\u201344. https:\/\/doi.org\/10.1345\/aph.1K671","journal-title":"Ann Pharmacother"},{"key":"9996_CR49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T et al (2012) A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73:691\u2013705. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04167.x","journal-title":"Br J Clin Pharmacol"},{"key":"9996_CR50","unstructured":"Differences between MPR and PDC | OpenHealth Knowledge Base [Internet]. [cited 2024 Jun 21]. Available from: https:\/\/success.openhealth.fr\/en\/articles\/3722666-differences-between-mpr-and-pdc"},{"key":"9996_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jval.2023.10.016","volume":"27","author":"T \u00c1gh","year":"2024","unstructured":"\u00c1gh T, Hiligsmann M, Borah B, Beaudart C, Turcu-Stiolica A, Manias E et al (2024) Systematic review of outcomes for assessment of medication adherence enhancing interventions: an ISPOR special interest group report. Value Health 27:133\u2013142. https:\/\/doi.org\/10.1016\/j.jval.2023.10.016","journal-title":"Value Health"},{"key":"9996_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pharma.2012.10.001","volume":"71","author":"B Allenet","year":"2013","unstructured":"Allenet B, Baudrant M, Lehmann A, Gauchet A, Roustit M, Bedouch P et al (2013) Comment \u00e9valuer l\u2019adh\u00e9sion m\u00e9dicamenteuse\u202f? Le point sur les m\u00e9thodes. Ann Pharm Fr 71:135\u2013141. https:\/\/doi.org\/10.1016\/j.pharma.2012.10.001","journal-title":"Ann Pharm Fr"},{"key":"9996_CR53","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1177\/0733464815602116","volume":"36","author":"VS Effoe","year":"2017","unstructured":"Effoe VS, Suerken CK, Quandt SA, Bell RA, Arcury TA (2017) The association of complementary therapy use with prescription medication adherence among older community-dwelling adults. J Appl Gerontol 36:1054\u20131069. https:\/\/doi.org\/10.1177\/0733464815602116","journal-title":"J Appl Gerontol"},{"key":"9996_CR54","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s40261-022-01199-7","volume":"42","author":"HG Tegegn","year":"2022","unstructured":"Tegegn HG, Wark S, Tursan d\u2019Espaignet E, Spark MJ (2022) Measurement properties of patient-reported outcome measures for medication adherence in cardiovascular disease: a COSMIN systematic review. Clin Drug Investig 42:879\u2013908. https:\/\/doi.org\/10.1007\/s40261-022-01199-7","journal-title":"Clin Drug Investig"},{"key":"9996_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182312445","volume":"18","author":"MLL Zini","year":"2021","unstructured":"Zini MLL, Banfi G (2021) A narrative literature review of bias in collecting patient reported outcomes measures (PROMs). Int J Environ Res Public Health 18:12445. https:\/\/doi.org\/10.3390\/ijerph182312445","journal-title":"Int J Environ Res Public Health"},{"key":"9996_CR56","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1310\/hct0904-238","volume":"9","author":"TJ Podsadecki","year":"2008","unstructured":"Podsadecki TJ, Vrijens BC, Tousset EP, Rode RA, Hanna GJ (2008) \u201cWhite coat compliance\u201d limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials 9:238\u2013246. https:\/\/doi.org\/10.1310\/hct0904-238","journal-title":"HIV Clin Trials"},{"key":"9996_CR57","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40265-019-01107-y","volume":"79","author":"H Wouters","year":"2019","unstructured":"Wouters H, Rhebergen D, Vervloet M, Egberts A, Taxis K, Van Dijk L et al (2019) Distinct profiles on subjective and objective adherence measures in patients prescribed antidepressants. Drugs 79:647\u2013654. https:\/\/doi.org\/10.1007\/s40265-019-01107-y","journal-title":"Drugs"},{"key":"9996_CR58","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1007\/s12325-023-02620-z","volume":"40","author":"T Salam","year":"2023","unstructured":"Salam T, Desai U, Lefebvre P, Jian-Yu E, Greatsinger A, Zacharia N et al (2023) Unintended consequences of increased out-of-pocket costs during Medicare coverage gap on anticoagulant discontinuation and stroke. Adv Ther 40:4523\u20134544. https:\/\/doi.org\/10.1007\/s12325-023-02620-z","journal-title":"Adv Ther"},{"key":"9996_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001075","volume":"8","author":"JM Polinski","year":"2011","unstructured":"Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, Schneeweiss S, Stuckler D, editor (2011) Changes in drug utilization during a gap in insurance coverage: an examination of the Medicare part D coverage gap. PLoS Med 8:e1001075. https:\/\/doi.org\/10.1371\/journal.pmed.1001075","journal-title":"PLoS Med"},{"key":"9996_CR60","first-page":"3061","volume":"6","author":"SS Coughlin","year":"2020","unstructured":"Coughlin SS, Vernon M, Hatzigeorgiou C, George V (2020) Health literacy, social determinants of health, and disease prevention and control. J Environ Health Sci. 6:3061 (PMID: 33604453; PMCID: PMC7889072)","journal-title":"J Environ Health Sci."},{"key":"9996_CR61","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013148","volume":"8","author":"H Lee","year":"2019","unstructured":"Lee H, Park JH, Floyd JS, Park S, Kim HC (2019) Combined effect of income and medication adherence on mortality in newly treated hypertension: nationwide study of 16 million person-years. J Am Heart Assoc 8:e013148. https:\/\/doi.org\/10.1161\/JAHA.119.013148","journal-title":"J Am Heart Assoc"},{"key":"9996_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/sjg.sjg_468_22","volume":"29","author":"AH Almakadma","year":"2023","unstructured":"Almakadma AH, De Vol A, Alabdaljabar MS, Aldosari S, Muhsen I, AlFreihi O et al (2023) Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases. Saudi J Gastroenterol 29:233\u2013239. https:\/\/doi.org\/10.4103\/sjg.sjg_468_22","journal-title":"Saudi J Gastroenterol"},{"key":"9996_CR63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1074248419865287","volume":"25","author":"A Ajrouche","year":"2020","unstructured":"Ajrouche A, Estellat C, De Rycke Y, Tubach F (2020) Trajectories of adherence to low-dose aspirin treatment among the French population. J Cardiovasc Pharmacol Ther 25:37\u201346. https:\/\/doi.org\/10.1177\/1074248419865287","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"5","key":"9996_CR64","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1200\/JCO.2005.03.9800","volume":"25","author":"FJ Hlubocky","year":"2007","unstructured":"Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK (2007) Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol 25(5):548\u2013554. https:\/\/doi.org\/10.1200\/JCO.2005.03.9800","journal-title":"J Clin Oncol"},{"key":"9996_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-018-0143-6","volume":"5","author":"G Smith","year":"2018","unstructured":"Smith G (2018) Step away from stepwise. J Big Data 5:32. https:\/\/doi.org\/10.1186\/s40537-018-0143-6","journal-title":"J Big Data"},{"key":"9996_CR66","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.1200\/JCO.2024.42.16_suppl.7547","volume":"42","author":"SM Belcher","year":"2024","unstructured":"Belcher SM, Sereika SM, Dunbar-Jacob J, Yeager K, Rosenzweig MQ, Agha ME et al (2024) Patterns and predictors of electronically measured oral anticancer medication (OAM) adherence among patients with multiple myeloma (MM). J Clin Oncol 42:7547\u20137547. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.7547","journal-title":"J Clin Oncol"},{"key":"9996_CR67","unstructured":"Commission nationale de l\u2019informatique et des libert\u00e9s (CNIL). D\u00e9cision 2015\u2013061 du 24 juin 2015 [Internet]. 2015\u2011061 24, 2015. Available from: https:\/\/www.legifrance.gouv.fr\/cnil\/id\/CNILTEXT000030950817. [cited 2025 Sep 1]"},{"key":"9996_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02496-3","volume":"23","author":"M Nili","year":"2023","unstructured":"Nili M, Epstein AJ, Nunag D, Olson A, Borah B (2023) Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients. BMC Pulm Med 23:230. https:\/\/doi.org\/10.1186\/s12890-023-02496-3","journal-title":"BMC Pulm Med"},{"key":"9996_CR69","unstructured":"ICH E6 Good clinical practice - Scientific guideline | European Medicines Agency (EMA) [Internet]. 2002 [cited 2025 Aug 5]. Available from: https:\/\/www.ema.europa.eu\/en\/ich-e6-good-clinical-practice-scientific-guideline"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09996-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T13:03:45Z","timestamp":1763211825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09996-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9996"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09996-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with good clinical practice guidelines for biomedical studies [\n                      \n                      ] and French regulations. The study protocol, patient-information note, and non-opposition consent form were approved by an ethics committee (CERAPHP 22\/07\/19, n\u00b0IDRCB 2018-AO3512-53).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All eligible patients agreed to participate in the study and signed a non-opposition consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"951"}}